Elicera Therapeutics AB (publ) announced that representatives of the largest owners have appointed the nomination committee ahead of the Annual General Meeting 2024. On May 10, the Annual General Meeting established rules to guide the work of the Nomination Committee. The three largest owners on September 30, 2023, were Magnus Essand, Di Yu and Jamal El-Mosleh, who together control 47.1% of the votes, and will be the election committee with Magnus Essand as chairman.